KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)

被引：0

作者：

Zhou, C. ^{[1
]}

Caglevic, C. ^{[2
]}

Zhou, J. ^{[3
]}

Wang, B. ^{[4
]}

Wang, K. ^{[5
]}

Ge, J. ^{[6
]}

Zhou, Y. ^{[6
]}

Piperdi, B. ^{[7
]}

Ma, Z. ^{[8
]}

机构：

[1] Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China

[2] FALP, Dept Oncol, Santiago, Chile

[3] Zhejiang Univ, Hosp 1, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[4] Subei Peoples Hosp, Dept Oncol, Yangzhou, Jiangsu, Peoples R China

[5] Zhejiang Univ, Hosp 2, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[6] MSD China, Oncol, Shanghai, Peoples R China

[7] Merck & Co Inc, Oncol, Kenilworth, NJ USA

[8] Henan Canc Hosp, Dept Oncol, Zhengzhou, Henan, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

466TiP

引用

页码：143 / 143

页数：1

共 50 条

[21] Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel: A Phase 1 Study in Japanese Patients with Previously Treated Non-Small-Cell Lung Cancer [J].

Okamoto, Isamu ;

Miyazaki, Masaki ;

Takeda, Masayuki ;

Terashima, Masaaki ;

Azuma, Koichi ;

Hayashi, Hidetoshi ;

Kaneda, Hiroyasu ;

Kurata, Takayasu ;

Tsurutani, Junji ;

Seto, Takashi ;

Hirai, Fumihiko ;

Konishi, Koichi ;

Sarashina, Akiko ;

Yagi, Nobutaka ;

Kaiser, Rolf ;

Nakagawa, Kazuhiko .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) :346-352

[22] Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial [J].

Rittmeyer, Achim ;

Barlesi, Fabrice ;

Waterkamp, Daniel ;

Park, Keunchil ;

Ciardiello, Fortunato ;

von Pawel, Joachim ;

Gadgeel, Shirish M. ;

Hida, Toyoaki ;

Kowalski, Dariusz M. ;

Dols, Manuel Cobo ;

Cortinovis, Diego L. ;

Leach, Joseph ;

Polikoff, Jonathan ;

Barrios, Carlos ;

Kabbinavar, Fairooz ;

Frontera, Osvaldo Aren ;

De Marinis, Filippo ;

Turna, Hande ;

Lee, Jong-Seok ;

Ballinger, Marcus ;

Kowanetz, Marcin ;

He, Pei ;

Chen, Daniel S. ;

Sandler, Alan ;

Gandara, David R. .

LANCET, 2017, 389 (10066) :255-265

[23] Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer [J].

Spigel, David R. ;

Greco, F. Anthony ;

Thompson, Dana S. ;

Webb, Charles ;

Rubinsak, James ;

Inhorn, Roger C. ;

Reeves, James, Jr. ;

Vazquez, Elizabeth R. ;

Lane, Cassie M. ;

Burris, Howard A., III ;

Hainsworth, John D. .

CLINICAL LUNG CANCER, 2010, 11 (03) :198-203

[24] A randomized Phase III study to compare the overall survival of gefitinib (IRESSA) versus docetaxel in Japanese patients with previously treated advanced non-small-cell lung cancer [J].

Sekine, Ikuo ;

Ichinose, Yukito ;

Nishiwaki, Yutaka ;

Yamamoto, Nobuyuki ;

Tsuboi, Masahiro ;

Nakagawa, Kazuhiko ;

Shinkai, Tetsu ;

Jiang Haiyi ;

Tamura, Tomohide ;

Fukuoka, Masahiro .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S339-S340

[25] Docetaxel and Exisulind in previously treated non-small cell lung cancer (NSCLC) patients: A multicenter, phase II clinical trial [J].

Weiss, Glen J. ;

Vokes, Everett E. ;

Bunn, Paul A., Jr. ;

Magree, Lyn ;

Rusk, Jason ;

Albert, Don ;

Kelly, Karen .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (10) :933-938

[26] SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC) [J].

Borghaei, H. ;

Johnson, M. L. ;

Garon, E. B. ;

He, K. ;

Planchard, D. ;

Reck, M. ;

Popat, S. ;

Herbst, R. S. ;

Leal, T. A. ;

Dumoulin, D. ;

De Marinis, F. ;

Reynolds, C. H. ;

Theelen, W. S. M. E. ;

Percent, I. ;

Calderon, V. Gutierrez ;

Flandin, A. C. Madroszyk ;

Shazer, R. L. ;

Yan, X. ;

Harrigan, R. ;

Peters, S. .

ANNALS OF ONCOLOGY, 2023, 34 :S1308-S1308

[27] Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Gerber, David E. ;

Spigel, David R. ;

Giorgadze, David ;

Shtivelband, Mikhail ;

Ponomarova, Olga V. ;

Shan, Joseph S. ;

Menander, Kerstin B. ;

Belani, Chandra P. .

CLINICAL LUNG CANCER, 2016, 17 (03) :169-176

[28] Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer [J].

Hanna, Nasser ;

Lilenbaum, Rogerio ;

Ansari, Rafat ;

Lynch, Thomas ;

Govindan, Ramaswamy ;

Jaenne, Pasi A. ;

Bonomi, Philip .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) :5253-5258

[29] Efficacy of docetaxel in non-small-cell lung cancer patients previously treated with paltinum-containing chemotherapy [J].

Robinet, G ;

Thomas, P ;

Pérol, M ;

Vergnenègre, A ;

Lena, H ;

Taytard, A ;

Paillotin, D ;

Bessa, EH ;

Schuller-Lebeau, MP .

REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (01) :83-89

[30] Phase I study of oral nintedanib combined with docetaxel in previously treated Japanese patients with advanced non-small cell lung cancer (NSCLC) [J].

Okamoto, I. ;

Miyazaki, M. ;

Takeda, M. ;

Azuma, K. ;

Hayashi, H. ;

Seto, T. ;

Konishi, K. ;

Sarashina, A. ;

Kaiser, R. ;

Nakagawa, K. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 :S830-S831

← 1 2 3 4 5 →